Pyrrho Capital Management LP Raised Its Neurocrine Biosciences (NBIX) Holding; Takung Art (NYSEMKT:TKAT) Sellers Decreased By 58.33% Their Shorts

August 7, 2017 - By test

Takung Art (NYSEMKT:TKAT) had a decrease of 58.33% in short interest. TKAT’s SI was 500 shares in August as released by FINRA. Its down 58.33% from 1,200 shares previously. With 2,500 avg volume, 0 days are for Takung Art (NYSEMKT:TKAT)’s short sellers to cover TKAT’s short positions. It is 0.00% or $0 reaching $3.45 per share. It is down 0.00% since August 7, 2016 and is . It has underperformed by 16.70% the S&P500.

Pyrrho Capital Management Lp increased Neurocrine Biosciences Inc (NBIX) stake by 113.97% reported in 2016Q4 SEC filing. Pyrrho Capital Management Lp acquired 29,404 shares as Neurocrine Biosciences Inc (NBIX)’s stock rose 19.84%. The Pyrrho Capital Management Lp holds 55,204 shares with $2.14 million value, up from 25,800 last quarter. Neurocrine Biosciences Inc now has $4.74 billion valuation. The stock rose 0.50% or $0.27 reaching $53.77 per share. About 403,384 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 12.51% since August 7, 2016 and is uptrending. It has underperformed by 4.19% the S&P500.

Investors sentiment decreased to 1.06 in Q4 2016. Its down 0.03, from 1.09 in 2016Q3. It worsened, as 33 investors sold NBIX shares while 67 reduced holdings. 23 funds opened positions while 83 raised stakes. 82.52 million shares or 1.88% less from 84.11 million shares in 2016Q3 were reported. Principal Fin Grp Inc holds 0% or 76,145 shares in its portfolio. Jpmorgan Chase And reported 0.01% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Deutsche Retail Bank Ag has 848,185 shares. Price T Rowe Associate Md, Maryland-based fund reported 5.98 million shares. Northern Trust Corp invested in 0.01% or 457,583 shares. Sg Americas Securities Limited Liability Corp owns 59,669 shares. Prelude Mngmt Lc holds 0.08% or 16,826 shares. Rock Springs LP has 1.06% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 410,000 shares. Dafna Capital Limited Company reported 66,008 shares stake. First Mercantile Company reported 2,522 shares. Panagora Asset Mngmt Inc holds 0% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 900 shares. 531,100 are held by Timessquare Mgmt Lc. Jennison Limited invested in 369,409 shares or 0.02% of the stock. Tocqueville Asset Management LP owns 24,625 shares or 0.01% of their US portfolio. The United Kingdom-based Dynamic Cap Management Ltd has invested 0.19% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX).

Among 10 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 18 analyst reports since August 18, 2015 according to SRatingsIntel. The company was maintained on Friday, August 4 by H.C. Wainwright. The rating was maintained by Cowen & Co with “Buy” on Friday, August 4. Jefferies maintained it with “Buy” rating and $6600 target in Monday, June 26 report. The stock of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has “Buy” rating given on Thursday, August 3 by BMO Capital Markets. On Wednesday, June 29 the stock rating was initiated by H.C. Wainwright with “Buy”. The firm has “Perform” rating given on Tuesday, November 22 by Oppenheimer. The stock has “Buy” rating by BMO Capital Markets on Friday, July 21. The rating was maintained by H.C. Wainwright with “Buy” on Tuesday, July 11. The firm earned “Buy” rating on Wednesday, July 5 by Oppenheimer. The rating was reinitiated by Jefferies on Tuesday, August 18 with “Buy”.

Since May 1, 2017, it had 0 insider buys, and 8 sales for $10.02 million activity. $533,900 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was sold by Grigoriadis Dimitri E.. Shares for $5.63 million were sold by OBrien Christopher Flint. Another trade for 5,000 shares valued at $269,900 was made by Nevinny Corinne H on Friday, May 5. Shares for $810,000 were sold by Gano Kyle. $532,700 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was sold by Lippoldt Darin on Thursday, May 18. Another trade for 9,960 shares valued at $534,155 was made by Lloyd-Smith Malcolm on Thursday, May 18. GORMAN KEVIN CHARLES sold $1.16 million worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Tuesday, May 2.

Takung Art Co., Ltd., formerly Cardigant Medical Inc., is a holding company. The company has market cap of $38.60 million. The Company, through HongKong Takung Assets and Equity of Artworks Exchange Co., Ltd. , and its subsidiaries, operates an electronic online platform located at www.takungae.com for artists, art dealers and art investors to offer and trade in artwork. It has a 6.39 P/E ratio. Through HongKong Takung and its subsidiaries Takung (Shanghai) Co., Ltd and Takung Cultural Development (Tianjin) Co.